(Q39539437)

12 September 2017

title

Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells (English)

1 reference

12 September 2017

1 reference

1 reference

1 reference

F Wang

1

1 reference

12 September 2017

W Ding

2

1 reference

12 September 2017

J Wang

3

1 reference

12 September 2017

R Jing

4

1 reference

12 September 2017

X Wang

5

1 reference

12 September 2017

H Cong

6

1 reference

12 September 2017

Y Wang

7

1 reference

12 September 2017

S Ju

8

1 reference

12 September 2017

H Wang

9

1 reference

12 September 2017

publication date

20 May 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

18

1 reference

12 September 2017

issue

7

1 reference

12 September 2017

page(s)

500-509

1 reference

Switching from repression to activation: microRNAs can up-regulate translation

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

(micro)Genomic medicine: microRNAs as therapeutics and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

MicroRNAs and apoptosis: implications in the molecular therapy of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

MicroRNA regulatory network in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

The impact of microRNAs on colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

A proliferation-inducing ligand: a new biomarker for non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

The source of APRIL up-regulation in human solid tumor lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

The expanding role of APRIL in cancer and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

APRIL is overexpressed in cancer: link with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

APRIL knockdown suppresses migration and invasion of human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Summaries of Affymetrix GeneChip probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Worldwide variations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

RNA interference as an anticancer therapy: a patent perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Strategies for short hairpin RNA delivery in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

MicroRNA-145 targets YES and STAT1 in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Diagnostic and prognostic microRNAs in stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

System-level feedbacks control cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Cell cycle, CDKs and cancer: a changing paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

A probabilistic framework to improve microrna target prediction by incorporating proteomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

Widespread changes in protein synthesis induced by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

inferred from DOI database lookup

7 January 2021

based on heuristic

Current progress in targeted therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.19

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2011.19

1 reference

12 September 2017

1 reference